|
End-of-day quote
NORDIC GROWTH MARKET
2026-09-30
|
5-day change | 1st Jan Change | ||
| 6.860 SEK | +1.48% |
|
-.--% | +0.88% |
| 11-04 | Abera Bioscience gets go-ahead for Phase 1 study of pneumococcal vaccine | FW |
| 10-14 | Preclinical data for Abera Bioscience's pneumococcal vaccine published in scientific journal | FW |
Chart: Technical Analysis
NORDIC GROWTH MARKETSEK
| Markets | Quality | ||
|---|---|---|---|
NORDIC GROWTH MARKET
| ABERA | End-of-day quote | |
Deutsche Boerse AG
| 8WK | Delayed | |
|
Deutsche Boerse AG
| 8WK | End-of-day quote |
- Stock Market
- Stocks
- ABERA Stock
- Charts Abera Bioscience AB
Select your edition
All financial news and data tailored to specific country editions
